title: Hypertriglyceridemic waist: the point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study.
abstract: OBJECTIVE
  We examined hypertriglyceridemic waist (HTGW) predictability for CVD and mortality.
  
  
  METHODS
  Among Tehran Lipid and Glucose Study's participants aged ≥30 (n=8071), we selected those who participated in the follow-up study until 20-March-2009 (n=7154). After exclusions (320 missing data on waist circumference or triglycerides), 6834 (3830 women) participants remained eligible with a total of 59,873 person-year follow-up. When CVD was outcome, we further excluded 426 participants with history of previous CVD.
  
  
  RESULTS
  All-cause mortality, CVD mortality, and incident CVD rate among men (per 1000-person-year) were 7.9 (95% CIs: 6.9-9.1), 4.1 (95% CIs: 3.4-5.0), and 13.0 (95% CIs: 11.7-14.6), respectively. Among women, corresponding figures were 3.7 (95% CIs: 3.1-4.4), 1.7 (95% CIs: 1.3-2.1), and 7.3 (95% CIs: 6.4-8.3), respectively. After adjustment for potential confounders, HTGW came to be inversely associated with all-cause mortality among both men (HR 0.384, 95% CIs 0.281-0.526) and women (HR 0.642, 95% CIs 0.430-0.958). Multivariate adjusted HR (95% CIs) of HTGW for CVD mortality was 0.453 (95% CIs 0.298-0.688) among men and 0.760 (95% CIs 0.431-1.338) among women. HTGW increased the age-adjusted risk of incident CVD, among both men (40%) and women (97%). The multivariate hazard ratio of HTGW for incident CVD was 0.945 (95% CIs 0.746-0.1.198, P value=0.640) among men and 1.470 among women (HR 95% CIs 1.111-1.944, P value=0.007).
  
  
  CONCLUSIONS
  HTGW was the point of divergence for prediction of CVD vs. mortality. HTGW, despite its predictive value for CVD, might not help in capturing risk of all-cause or CVD mortality. Individuals without HTGW constitute a heterogeneous subgroup with a jumble of risk factors that put them at risk for all-cause or CVD mortality.
authors.affiliation: Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
authors.forename: Shiva
authors.initials: S
authors.lastname: Samadi
authors.forename: Mohammadreza
authors.initials: M
authors.lastname: Bozorgmanesh
authors.forename: Davood
authors.initials: D
authors.lastname: Khalili
authors.forename: Amirabbas
authors.initials: A
authors.lastname: Momenan
authors.forename: Farhad
authors.initials: F
authors.lastname: Sheikholeslami
authors.forename: Fereidoun
authors.initials: F
authors.lastname: Azizi
authors.forename: Farzad
authors.initials: F
authors.lastname: Hadaegh
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000401:mortality*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D064250:Hypertriglyceridemic Waist / Q000175:diagnosis* / Q000453:epidemiology / Q000401:mortality*; D007492:Iran / Q000453:epidemiology; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D055105:Waist Circumference / Q000502:physiology
chemical_list: D001786:Blood Glucose; D008055:Lipids